| A To Z Hospice Care Inc 1202 Monte Vista Avenue Suite #4, Upland, CA, 91786 | |
| (909) 982-0847 |
News Archive
At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research at Washington University School of Medicine in St. Louis.
Using a hand-held spectral domain optical coherence tomography (SD-OCT) imaging device, researchers have obtained high-resolution retinal scans of premature infants with progressive retinopathy of prematurity (ROP), according to a report in this month's Archives of Ophthalmology.
iSOFT Group Limited, one of the world's largest healthcare information technology companies, today announced a strategic partnership with Lumetra PSO, a US Government-backed Patient Safety Organization (PSO). Lumetra agreed to provide iSOFT's AIMS incident management software to US healthcare organizations that are seeking to reduce the complexity and cost of their patient safety and risk management programs.
The Center for Health Promotion and Disease Prevention at the University of North Carolina at Chapel Hill has received a five-year, $3.8 million grant from the National Heart, Lung, and Blood Institute to fund research that will address the challenge of achieving long-term weight loss among patients with obesity cared for at primary care practices.
A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).
› Verified 1 days ago
| Name | A To Z Hospice Care Inc |
|---|---|
| Location | 1202 Monte Vista Avenue Suite #4, Upland, California |
| Hospice ID | 551755 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | The Joint Commission (TJC) |
| SSA county code | 460 |
News Archive
At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research at Washington University School of Medicine in St. Louis.
Using a hand-held spectral domain optical coherence tomography (SD-OCT) imaging device, researchers have obtained high-resolution retinal scans of premature infants with progressive retinopathy of prematurity (ROP), according to a report in this month's Archives of Ophthalmology.
iSOFT Group Limited, one of the world's largest healthcare information technology companies, today announced a strategic partnership with Lumetra PSO, a US Government-backed Patient Safety Organization (PSO). Lumetra agreed to provide iSOFT's AIMS incident management software to US healthcare organizations that are seeking to reduce the complexity and cost of their patient safety and risk management programs.
The Center for Health Promotion and Disease Prevention at the University of North Carolina at Chapel Hill has received a five-year, $3.8 million grant from the National Heart, Lung, and Blood Institute to fund research that will address the challenge of achieving long-term weight loss among patients with obesity cared for at primary care practices.
A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).
› Verified 1 days ago
| NPI Number | 1518246719 |
| Organization Name | A To Z Hospice Care, Inc. |
| Address | 1202 Monte Vista Avenue Upland, California, 91786 |
| Phone Number | (909)982-0847 |
News Archive
At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research at Washington University School of Medicine in St. Louis.
Using a hand-held spectral domain optical coherence tomography (SD-OCT) imaging device, researchers have obtained high-resolution retinal scans of premature infants with progressive retinopathy of prematurity (ROP), according to a report in this month's Archives of Ophthalmology.
iSOFT Group Limited, one of the world's largest healthcare information technology companies, today announced a strategic partnership with Lumetra PSO, a US Government-backed Patient Safety Organization (PSO). Lumetra agreed to provide iSOFT's AIMS incident management software to US healthcare organizations that are seeking to reduce the complexity and cost of their patient safety and risk management programs.
The Center for Health Promotion and Disease Prevention at the University of North Carolina at Chapel Hill has received a five-year, $3.8 million grant from the National Heart, Lung, and Blood Institute to fund research that will address the challenge of achieving long-term weight loss among patients with obesity cared for at primary care practices.
A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).
› Verified 1 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 100.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 97.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 63.0 | 93.3 |
News Archive
At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research at Washington University School of Medicine in St. Louis.
Using a hand-held spectral domain optical coherence tomography (SD-OCT) imaging device, researchers have obtained high-resolution retinal scans of premature infants with progressive retinopathy of prematurity (ROP), according to a report in this month's Archives of Ophthalmology.
iSOFT Group Limited, one of the world's largest healthcare information technology companies, today announced a strategic partnership with Lumetra PSO, a US Government-backed Patient Safety Organization (PSO). Lumetra agreed to provide iSOFT's AIMS incident management software to US healthcare organizations that are seeking to reduce the complexity and cost of their patient safety and risk management programs.
The Center for Health Promotion and Disease Prevention at the University of North Carolina at Chapel Hill has received a five-year, $3.8 million grant from the National Heart, Lung, and Blood Institute to fund research that will address the challenge of achieving long-term weight loss among patients with obesity cared for at primary care practices.
A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).
› Verified 1 days ago
| Home Health Aides | 3 |
| Licensed Practical or Vocational Nurses | 3 |
| Medical Social Workers | 1 |
| Physicians | 1 |
| Registered Nurses | 2 |
| Other Personnel | 4 |
| Total Employees | 14 |
|---|
News Archive
At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research at Washington University School of Medicine in St. Louis.
Using a hand-held spectral domain optical coherence tomography (SD-OCT) imaging device, researchers have obtained high-resolution retinal scans of premature infants with progressive retinopathy of prematurity (ROP), according to a report in this month's Archives of Ophthalmology.
iSOFT Group Limited, one of the world's largest healthcare information technology companies, today announced a strategic partnership with Lumetra PSO, a US Government-backed Patient Safety Organization (PSO). Lumetra agreed to provide iSOFT's AIMS incident management software to US healthcare organizations that are seeking to reduce the complexity and cost of their patient safety and risk management programs.
The Center for Health Promotion and Disease Prevention at the University of North Carolina at Chapel Hill has received a five-year, $3.8 million grant from the National Heart, Lung, and Blood Institute to fund research that will address the challenge of achieving long-term weight loss among patients with obesity cared for at primary care practices.
A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).
› Verified 1 days ago
| Others | 1 |
| Total Volunteers | 1 |
|---|
News Archive
At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research at Washington University School of Medicine in St. Louis.
Using a hand-held spectral domain optical coherence tomography (SD-OCT) imaging device, researchers have obtained high-resolution retinal scans of premature infants with progressive retinopathy of prematurity (ROP), according to a report in this month's Archives of Ophthalmology.
iSOFT Group Limited, one of the world's largest healthcare information technology companies, today announced a strategic partnership with Lumetra PSO, a US Government-backed Patient Safety Organization (PSO). Lumetra agreed to provide iSOFT's AIMS incident management software to US healthcare organizations that are seeking to reduce the complexity and cost of their patient safety and risk management programs.
The Center for Health Promotion and Disease Prevention at the University of North Carolina at Chapel Hill has received a five-year, $3.8 million grant from the National Heart, Lung, and Blood Institute to fund research that will address the challenge of achieving long-term weight loss among patients with obesity cared for at primary care practices.
A study led by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center/NewYork-Presbyterian and chairman of the Cardiovascular Research Foundation, has shown that heart attack patients who were administered the direct thrombin inhibitor bivalirudin during primary angioplasty had a reduced rate of adverse clinical events, a lower rate of major bleeding, and a lower mortality rate than those who were treated with a regimen of heparin and glycoprotein IIb/IIIa inhibitors (GPI).
› Verified 1 days ago
| St Grace Hospice Inc Location: 904 West Ninth Street, Upland, California, 91786 Phone: (909) 982-0847 |
| Ghc Hospice Inc Location: 906 W 9th Street, Upland, California, 91786 Phone: (909) 982-0847 |
| A To Z Hospice Care Inc Location: 1202 Monte Vista Avenue Suite #4, Upland, California, 91786 Phone: (909) 982-0847 |
| Pandora Hospice Care Inc Location: 600 N Mountain Avenue Suite A201, Upland, California, 91786 Phone: (909) 982-0847 |